Hill-Rom, which is the world's leading hospital bed manufacturer, has teamed-up with EarlySense to integrate their continuous contact-free heart rate and respiratory rate sensing and analytics technology into Hill-Rom's Centrella Smart+ bed platform.

Specific improved clinical outcomes demonstrated with this technology include helping reduce mortality related to "code blue" events by 83 percent, and cardiac arrests by 86 percent. Furthermore, clinicians reported overall hospital length-of-stay was reduced by 9 percent, and ICU days by 45 percent. Additionally, several EarlySense customers have reported that the system also assisted with early detection of sepsis, a condition that, when not identified and treated rapidly, may be life-threatening.

"Hill-Rom's Centrella bed is transforming inpatient care by integrating advanced sensing and analytics into the bed, offering a complete patient safety platform to assist clinicians in providing the highest level of care," John Groetelaars, president and CEO of Hill-Rom, said in a statement. "EarlySense has been used to effectively monitor close to a million patients, positively affecting patient outcomes. By integrating the EarlySense technology into our Centrella beds, we are ushering in a new era in quality of care, whereby all patients can be continuously monitored throughout their entire hospital stay."

EarlySense co-founder and CEO Avner Halperin is also pleased with the deal. "Integrating EarlySense monitoring capabilities with the Hill-Rom Centrella bed platform will advance our collective aspiration of having every patient in every hospital continuously monitored for safe, data-driven care, with the potential to save thousands of lives and significant costs for the healthcare system," he said.